Cited by 36Dementia and Cognitive Impairment ResearchEpigenetics and DNA MethylationAlzheimer's disease research and treatments

Blood DNA methylation signatures to detect dementia prior to overt clinical symptoms

Open access
Fransquet, Peter Daniel, Lacaze, Paul, Saffery, Richard, Phung, James, Parker, Emily, Shah, Raj, Murray, Anne, Woods, Robyn L. +1 more·2020·Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Abstract

Introduction This study determined whether blood DNA methylation (DNAm) patterns differentiate individuals with presymptomatic dementia compared to controls. Methods DNAm was measured in 73 individuals prior to dementia diagnosis and 87 cognitively healthy controls matched for age, sex, smoking, education, and baseline cognition. DNAm was also measured at 3 years follow-up in 25 dementia cases, and 24 controls. Results Cases and controls differed in DNAm (unadjusted P < .01) at the time of diagnosis (n = 28,787 probes), and pre-diagnosis (n = 15,111 probes), with cg01404610 (General transcription factor IIA subunit 1 gene) significant after correction for multiple testing. Overall, 1150 probes overlapped between analyses (methylation differences from –10.6% to +11.0%), and effect sizes increased from pre-diagnosis to diagnosis. Discussion Discernible blood DNAm signatures are in dementia cases before the appearance of overt clinical symptoms. Blood-based methylation may serve as a potential biomarker of dementia, but further investigation is needed to determine their true clinical utility.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/dad2.12056

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • DNA methylation alterations can be detected in the blood of AD subjects.

    “and can also be detected in the blood of AD subjects [25–31].”

    From Distinct sex-specific DNA methylation differences in Alzheimer’s disease (2022) · cites this paper as [26]

    The Highlights report that blood DNA methylation differs between dementia cases and controls. The Discussion says the study could not distinguish cases by the underlying cause of dementia, so its findings do not establish the alteration specifically in AD subjects. Page numbers were not available in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 49 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. [1]Duong S, Patel T, Chang F. Dementia: what pharmacists need to know. Can Pharm J (Ott). 2017; 150(2): 118‐ 129. 28405256 PMC5384525
  2. [30]Stouffer SA, Suchman EA, Devinney LC, Star SA, Williams Jr RM. The American Soldier: Adjustment During Army Life. (Studies in Social Psychology in World War II). Oxford: Princeton University Press; 1949.

Cited by

Sorted by citations

Authors
Fransquet, P. D., Lacaze, P., Saffery, R., Phung, J., Parker, E., Shah, R., Murray, A., Woods, R. L., & Ryan, J.
Affiliations
  • Monash University (AU)
  • The University of Melbourne (AU)
  • Rush University Medical Center (US)
  • University of Minnesota (US)
  • Inserm (FR)
Corresponding author
Ryan, Joanne
Venue
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Publisher
Wiley
Published
2020-01
Volume
12
Issue
1
Pages
e12056-e12056
ISSN
2352-8729 (ISSN-L)
OpenAlex
W3041867596
Cited by
36
References
49
Citations by year
2026: 3 · 2025: 4 · 2024: 6 · 2023: 8 · 2022: 10 · 2021: 4 · 2020: 1
FWCI
4.20
Type
journal article
Language
en
Open access
Locations
  • Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Monash University Research Portal (Monash University) (submittedVersion, cc-by-nc)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Own your potential (DEAKIN) (submittedVersion)
  • Figshare (submittedVersion, cc-by-nc)
Funders
  • National Institutes of Health (U01AG029824)
  • National Health and Medical Research Council (334047, 1127060, APP1135727)
  • Victorian Cancer Agency
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
blood DNA methylation, dementia biomarkers, epigenetic signatures, early detection of dementia, longitudinal methylation changes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review